FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome

Amifampridine (Firdapse) is approved for adults with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder characterized by muscle weakness.
FDA Approvals

Source link

Related posts

You Behind The Illness


Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson’s disease.


Patients with fibromyalgia reporting severe pain but low impact of the syndrome: clinical and pain-related cognitive features.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World